TAI LCx

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameTAI LCx
Drug Alias NameTAI-LCx
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin modulatorsTumor necrosis factor α modulators
TargetsProstaglandinTumor necrosis factor α
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBotanisol LLC
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A